Skip to content

EBITDA at other companies

IAR
Integra LifeSciencesIART
$53.68M+111%
MiMedx Group logo
MiMedx GroupMDXG
-$15.75M-232%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+0.2%
Bioventus logo
BioventusBVS
$19.62M+17.3%
Axogen logo
AxogenAXGN
-$1.23M-1,933%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$20.4M+34.4%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

$68.9Mebit+
$4.2MDepreciation Depletion & Amortization
=-$64.72M

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s EBITDA?
Organogenesis Holdings Inc. (ORGO) reported EBITDA of -$64.72M in Q1 2026.
How has Organogenesis Holdings Inc.'s EBITDA changed year-over-year?
Organogenesis Holdings Inc.'s EBITDA decreased by 177.7% year-over-year, from -$23.3M to -$64.72M.
What is the long-term trend for Organogenesis Holdings Inc.'s EBITDA?
Over 2 years (2021 to 2025), Organogenesis Holdings Inc.'s EBITDA has grown at a -15.0% compound annual growth rate (CAGR), from $82.95M to $59.97M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.